Word count: 2,270 TWST: We’ve spoken before, but just for readers who may not be familiar, let’s start with a refresher on the company, its mission, and some milestones. Mr. Do: BioVie has two ...

In addition, the event will highlight M6P's S1S3 co-expression platform technology, designed to enhance mannose 6-phosphate (M6P) content on lysosomal enzymes to increase lysosomal targeting to ...

In addition, the event will highlight M6P's S1S3 co-expression platform technology, designed to enhance mannose 6-phosphate (M6P) content on lysosomal enzymes to increase lysosomal targeting to ...

Montreal, QC H3B 2S2 The following hockey-themed experiences to engage fans by 4 Nations Face-Off partners will be available during operating hours at the 4 Nations Fan Festival in Montreal.

Scientists have created a novel technology for developing antibody (M6P) conjugates without enzyme modification in vitro, ...

Marisa Leuzzi, Toronto, ON, M6P, (647) 952-6585, Are you a caregiver looking for support for your child or teen experiencing behavioural challenges? I can understand how difficult it can be to ...

Reenie Perkovic, Registered Psychotherapist (Qualifying), Toronto, ON, M6P, (416) 966-5123, I’m Reenie (she/they) and I’m a queer therapist who values the importance of lived experiences and ...

In five poster presentations, including two Contemporary Forum presentations, M6P Therapeutics’ researchers report preclinical efficacy results for LSDs, including Gaucher disease and Pompe disease.

M6P Therapeutics announced a poster presentation at the 29th Annual Congress of the European Society of Gene and Cell Therapy (ESGCT) 2022.

- Preclinical data provide proof of concept for M002 to restore cellular uptake and lysosomal delivery and attenuate phenotype in mouse models of mucolipidosis type II - - M002 leverages the Company’s ...